Column GROUP Gp, L.P., 10% Owner, Director at NGM BIOPHARMACEUTICALS INC (NGM), bought 184,272 shares at $5.00 ($921K) on 2023-01-31, disclosed to the SEC on 2023-02-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 7,542 | $38K | 4.1% |
| 2 | $5.00 | 176,730 | $884K | 95.9% |
| Total | $5.00 avg | 184,272 | $921K | 100% |
| Filing → |
| NGM | BUY | 2022-05-11 | $2.5M | — | Filing → |
| NGM | BUY | 2019-11-13 | $180 | — | Filing → |
| CNST | BUY | 2019-10-07 | $12.0M | — | Filing → |